AFT Pharmaceuticals Limited

NZSE AFT.NZ

AFT Pharmaceuticals Limited Market Capitalization on January 14, 2025: USD 170.34 M

AFT Pharmaceuticals Limited Market Capitalization is USD 170.34 M on January 14, 2025, a -29.57% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • AFT Pharmaceuticals Limited 52-week high Market Capitalization is USD 246.13 M on February 07, 2024, which is 44.49% above the current Market Capitalization.
  • AFT Pharmaceuticals Limited 52-week low Market Capitalization is USD 147.74 M on November 17, 2024, which is -13.27% below the current Market Capitalization.
  • AFT Pharmaceuticals Limited average Market Capitalization for the last 52 weeks is USD 196.25 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
NZSE: AFT.NZ

AFT Pharmaceuticals Limited

CEO Dr. Hartley Atkinson Ph.D.
IPO Date Dec. 21, 2015
Location New Zealand
Headquarters 129 Hurstmere Road
Employees 110
Sector Health Care
Industries
Pharmaceuticals
Description

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

StockViz Staff

January 15, 2025

Any question? Send us an email